ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001

Center For Health Policy And Outcomes Established At Memorial Sloan Kettering. ONS Marks 35th Year.

July 9, 2010